Inhibiting CD146 by its Monoclonal Antibody AA98 Improves Radiosensitivity of Cervical Cancer Cells

BACKGROUND Cervical Cancer is one of the major causes of Cancer death of females worldwide. Radiotherapy is considered effective for cervical Cancer treatment, but the low radiosensitivity found in some cases severely affects therapeutic outcomes. This study aimed to reveal the role of CD146, an important adhesion molecule facilitating tumor angiogenesis, in regulating radiosensitivity of cervical Cancer cells. MATERIAL AND METHODS CD146 protein expression was compared in normal cells, cervical Cancer cells with lower radiosensitivity, and cervical Cancer cells with higher sensitivity from cervical squamous cell carcinoma patients. Anti-CD146 monoclonal antibody AA98 was used to inhibit CD146 in human cervical Cancer SiHa cells with relatively low radiosensitivity, and then the cell survival and Apoptosis changes after radiation were detected by colony formation assay and flow cytometry. RESULTS CD146 protein was significantly up-regulated in cervical Cancer cells (P<0.001), especially in Cancer cells with lower radiosensitivity. The SiHa cells treated with AA98 showed more obvious inhibition in cell survival (P<0.05) and promotion in cell Apoptosis (P<0.01) after radiation, compared to the untreated cells. More dramatic changes in apoptotic factors Caspase 3 and Bcl-xL were also detected in AA98-treated cells. CONCLUSIONS These results indicate that inhibiting CD146 improves the effect of radiation in suppressing SiHa cells. This study shows the potential of CD146 as a target for increasing radiosensitivity of cervical Cancer cells, which might allow improvement in treatment outcome in cervical Cancer. Further studies are necessary for understanding the detailed mechanism of CD146 in regulating radiosensitivity.